A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes
Not Applicable
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 2Pre Diabetes
- Interventions
- Other: Produce Prescription Group
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 134
- Registration Number
- NCT05939349
Daily Inclusion of Eggs in a Heart-Healthful Dietary Pattern in Hyperlipidemic Adults
Not Applicable
Recruiting
- Conditions
- Hyperlipidemias
- Interventions
- Other: DASH eating plan with eggsOther: DASH eating plan without eggs
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT05807334
- Locations
- 🇺🇸
Yale-Griffin Prevention Research Center, Derby, Connecticut, United States
Effects of Fos Biomedical Device on Diabetes Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Pre Diabetes
- Interventions
- Device: Fos Biomedical patch product
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 34
- Registration Number
- NCT05628597
- Locations
- 🇺🇸
Yale-Griffin Prevention Research Center, Derby, Connecticut, United States
COVID-19 Booster Vaccination in Persons With Multiple Sclerosis
Early Phase 1
Terminated
- Conditions
- Multiple Sclerosis
- Interventions
- Biological: Heterologous boosterBiological: Homologous booster
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05081271
- Locations
- 🇺🇸
Griffin Hospital, Derby, Connecticut, United States
The Impact of Consumption of Eggs in the Context of Plant-Based Diets on Endothelial Function, Diet Quality, and Cardio-Metabolic Risk Factors in Adults at Risk for Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Cardiovascular DiseasesType 2 Diabetes
- Interventions
- Other: Vegan PhaseOther: Egg included vegan phase
- First Posted Date
- 2020-03-20
- Last Posted Date
- 2021-08-10
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT04316429
- Locations
- 🇺🇸
Yale-Griffin Prevention Research Center, Derby, Connecticut, United States
Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis
Early Phase 1
Active, not recruiting
- Conditions
- Multiple Sclerosis
- Interventions
- Biological: Fecal microbial transplant (FMT)
- First Posted Date
- 2019-09-19
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT04096443
- Locations
- 🇺🇸
Griffin Hospital, Derby, Connecticut, United States
Post-prandial Effects of Extra Virgin Olive Oil on Endothelial Function in Adults at Risk for Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Other: Refined Olive OilOther: Extra Virgin Olive Oil
- First Posted Date
- 2019-07-18
- Last Posted Date
- 2020-03-30
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04025281
- Locations
- 🇺🇸
Yale-Griffin Prevention Research Center, Derby, Connecticut, United States
Mindfulness Meditation in Treating Insomnia in Multiple Sclerosis
Not Applicable
Completed
- Conditions
- Insomnia ChronicMultiple Sclerosis
- Interventions
- Behavioral: Mindfulness InterventionBehavioral: Sleep Hygiene
- First Posted Date
- 2019-05-14
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT03949296
- Locations
- 🇺🇸
Yale-Griffin Prevention Research Center, Derby, Connecticut, United States
Teriflunomide Male Transmission Study
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2016-02-10
- Last Posted Date
- 2019-01-02
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02679885
- Locations
- 🇺🇸
Multiple Sclerosis Treatment Center at Griffin Hospital, Derby, Connecticut, United States
Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Dietary Supplement: ISOThrive SupplementDietary Supplement: Placebo Supplement
- First Posted Date
- 2015-07-17
- Last Posted Date
- 2020-03-26
- Lead Sponsor
- Griffin Hospital
- Target Recruit Count
- 103
- Registration Number
- NCT02501356
- Locations
- 🇺🇸
Yale-Griffin Prevention Research Center, Derby, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath